May 23, 2012
Blood Thinner From Bayer, J&J Hits Hurdle
Blood Thinner From Bayer, J&J Hits Hurdle: A federal advisory panel narrowly voted against expanded use of Johnson & Johnson's and Bayer's anticlotting drug Xarelto
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment